32 (6.4) 7 (2.0) Difficulty concentrating 25 (5.0) 5 (1.4) Difficulty with memory 77 (15.5) 29 (8.3) Dizziness 20 (4.0) 10 (2.9) Emotional lability/moodiness 33 (6.6) 22 (6.3) Fatigue 8 (1.6) 4 (1.1) Hypesthesia 6 (1.2) 3 (0.9) Incoordination 27 (5.4) 11 (3.1) Insomnia 15 (3.0) 7 (2.0) Mental slowing 9 (1.8) 3 (0.9) Nervousness 18 (3.6) 7 (2.0) Nystagmus 16 (3.2) 6 (1.7) Paresthesia 8 (1.6) 3 (0.9) Psychomotor slowing 5 (1.0) 3 (0.9) Psychosis/Psychotic Disorder 7 (1.4) 2 (0.6) Schizophrenic/Schizophreniform behaviour 80 (16.1) 29 (8.3) Somnolence 29 (5.8) 6 (1.7) Speech & Language abnormalities 43 (8.6) 24 (6.9) Tiredness 16 (3.2) 7 (2.0) Tremor Renal and Urinary disorders >1% Nephrolithiasis* Respiratory 8 (1.6) 4 (1.1) Cough increased 21 (4.2) 10 (2.9) Pharyngitis 8 (1.6) 4 (1.1) Rhinitis 7 (1.4) 4 (1.1) Sinusitis Skin and Appendages 5 (1.0) 2 (0.6) Acne 14 (2.8) 8 (2.3) Rash 5 (1.0) 1 (0.3) Sweating Special senses
Difficulty concentrating 32 (6.4) 7 (2.0) Difficulty with memory 25 (5.0) 5 (1.4) Dizziness 77 (15.5) 29 (8.3) Emotional lability/moodiness 20 (4.0) 10 (2.9) Fatigue 33 (6.6) 22 (6.3) Hypesthesia 8 (1.6) 4 (1.1) Incoordination 6 (1.2) 3 (0.9) Insomnia 27 (5.4) 11 (3.1) Mental slowing 15 (3.0) 7 (2.0) Nervousness 9 (1.8) 3 (0.9) Nystagmus 18 (3.6) 7 (2.0) Paresthesia 16 (3.2) 6 (1.7) Psychomotor slowing 8 (1.6) 3 (0.9) Psychosis/Psychotic Disorder 5 (1.0) 3 (0.9) Schizophrenic/Schizophreniform behaviour 7 (1.4) 2 (0.6) Somnolence 80 (16.1) 29 (8.3) Speech & Language abnormalities 29 (5.8) 6 (1.7) Tiredness 43 (8.6) 24 (6.9) Tremor 16 (3.2) 7 (2.0) Renal and Urinary disorders Nephrolithiasis* >1% Respiratory Cough increased 8 (1.6) 4 (1.1) Pharyngitis 21 (4.2) 10 (2.9) Rhinitis 8 (1.6) 4 (1.1) Sinusitis 7 (1.4) 4 (1.1) Skin and Appendages Acne 5 (1.0) 2 (0.6) Rash 14 (2.8) 8 (2.3) Sweating 5 (1.0) 1 (0.3) Special senses
auspar-zonisamide-130722-pi.docx